ResMed has appointed Shubhi Khurana as general manager for India and South Asia.
Khurana, former general manager of Capsugel India Region (now Lonza), oversees business operations including setting strategic priorities, evolving team and go-to-market models for ResMed’s long-term growth. She aims to enhance ResMed’s leadership in the region by enabling efforts in developing innovative technology-enabled care pathways and improving patients’ therapy experiences.
These initiatives also encompass market development and awareness measures to educate the public, medical community, and decision makers about the prevalence of sleep and respiratory diseases in South Asia, as well as how to diagnose and treat them at home with cloud-connectable non-invasive devices. These campaigns support efforts to address the under-penetration of sleep and respiratory care markets in India and neighboring countries.
“Sleep apnea and COPD are global health epidemics and are especially prevalent in Asia,” says Justin Leong, president of ResMed’s Asia Growth Markets, in a release. “In India, these diseases are highly underdiagnosed due to low awareness amongst both doctors and the general community. Given the link between these diseases, and other chronic diseases like diabetes, hypertension, stroke, cognitive disorders, and cancer, it is critical we continue to educate and treat people with these conditions. We are thrilled to have Shubhi join us at this important time.”
Khurana says, “I am excited to accept this critical role and to grow both public awareness of the health epidemics ResMed helps treat and ResMed’s own reputation as an important digital health leader in this space. Research on the impacts of sleep apnea and COPD are only a few decades old. Therefore, the potential to make an impact in people lives and their health through ResMed’s innovative offerings is a great opportunity in itself.”
Khurana has more than two decades of experience in the pharmaceutical, healthcare, and medtech industries in various leadership roles. Before Capsugel, she worked at Baxter and Baxalta (now Takeda), building its critical care, rare diseases, and surgical kits business.